SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection

被引：0
|
作者：
Felice Gragnano
Fabrizia Terracciano
Paolo Calabrò
机构：
[1] University of Campania “Luigi Vanvitelli”,Department of Translational Medical Sciences
[2] A.O.R.N. “Sant’Anna e San Sebastiano”,Division of Clinical Cardiology
来源：
Journal of Cardiovascular Translational Research | 2024年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：227 / 229
页数：2
相关论文
共 50 条
  • [21] Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data
    Hallow, K. Melissa
    Greasley, Peter J.
    Helmlinger, Gabriel
    Chu, Lulu
    Heerspink, Hiddo J.
    Boulton, David W.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (05) : F1295 - F1306
  • [22] SGLT2 Inhibitors - The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
    Seidu, Samuel
    Alabraba, Vicki
    Davies, Sarah
    Newland-Jones, Philip
    Fernando, Kevin
    Bain, Stephen C.
    Diggle, Jane
    Evans, Marc
    James, June
    Kanumilli, Naresh
    Milne, Nicola
    Viljoen, Adie
    Wheeler, David C.
    Wilding, John P. H.
    DIABETES THERAPY, 2024, 15 (05) : 1099 - 1124
  • [23] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Clifford J. Bailey
    Caroline Day
    Srikanth Bellary
    Current Diabetes Reports, 2022, 22 : 39 - 52
  • [24] Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
    Bailey, Clifford J.
    Day, Caroline
    Bellary, Srikanth
    CURRENT DIABETES REPORTS, 2022, 22 (01) : 39 - 52
  • [25] Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
    O'Hara, D. V.
    Neuen, B. L.
    Jardine, M. J.
    JOURNAL OF NEPHROLOGY, 2020, 33 (05) : 977 - 983
  • [26] Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE
    D. V. O’Hara
    B. L. Neuen
    M. J. Jardine
    Journal of Nephrology, 2020, 33 : 977 - 983
  • [27] Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance
    Ray, Evan C.
    CURRENT OPINION IN PHARMACOLOGY, 2020, 54 : 11 - 17
  • [28] Mechanisms of Protective Effects of SGLT2 Inhibitors in Cardiovascular Disease and Renal Dysfunction
    Liu, Ban
    Wang, Yuliang
    Zhang, Yangyang
    Yan, Biao
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (20) : 1818 - 1849
  • [29] Renal effects of SGLT2 inhibitors: an update
    Nespoux, Josselin
    Vallon, Volker
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (02): : 190 - 198
  • [30] Renal and cardiac effects of SGLT2 inhibitors
    Menne J.
    Der Nephrologe, 2017, 12 (2): : 90 - 96
12345